162 related articles for article (PubMed ID: 21231852)
1. The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes.
Kuć P; Kuczyńska A; Topczewska M; Tadejko P; Kuczyński W
Gynecol Endocrinol; 2011 Nov; 27(11):867-73. PubMed ID: 21231852
[TBL] [Abstract][Full Text] [Related]
2. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles.
Detti L; Yelian FD; Kruger ML; Diamond MP; Puscheck EE
J Ultrasound Med; 2008 Nov; 27(11):1591-6. PubMed ID: 18946098
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
4. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
5. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles.
Pabuccu R; Onalan G; Kaya C
Fertil Steril; 2007 Oct; 88(4):832-9. PubMed ID: 17428479
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
8. Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial.
Gizzo S; Andrisani A; Esposito F; Noventa M; Di Gangi S; Angioni S; Litta P; Gangemi M; Nardelli GB
Gynecol Endocrinol; 2014; 30(12):902-8. PubMed ID: 25268567
[TBL] [Abstract][Full Text] [Related]
9. Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.
Zhang J; Sun YF; Xu YM; Shi BJ; Han Y; Luo ZY; Zhao ZM; Hao GM; Gao BL
Front Endocrinol (Lausanne); 2021; 12():578783. PubMed ID: 34079517
[TBL] [Abstract][Full Text] [Related]
10. Mini-dose GnRH-a long versus short protocol in patients ≥ 35 years old undergoing in vitro fertilization.
Xu HJ; Ji XW; Hong Y; Zhu QL; Zhao XM; Sun Y
Gynecol Endocrinol; 2014 Jul; 30(7):498-501. PubMed ID: 24693851
[TBL] [Abstract][Full Text] [Related]
11. GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.
Prapas Y; Petousis S; Dagklis T; Panagiotidis Y; Papatheodorou A; Assunta I; Prapas N
Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):43-6. PubMed ID: 23020996
[TBL] [Abstract][Full Text] [Related]
12. Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration.
Wu Y; Gao X; Lu X; Xi J; Jiang S; Sun Y; Xi X
Reprod Biol Endocrinol; 2014 Oct; 12():96. PubMed ID: 25296555
[TBL] [Abstract][Full Text] [Related]
13. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist.
Kolanska K; Cohen J; Bendifallah S; Selleret L; Antoine JM; Chabbert-Buffet N; Darai E; d'Argent EM
J Gynecol Obstet Hum Reprod; 2017 Nov; 46(9):681-686. PubMed ID: 28970135
[TBL] [Abstract][Full Text] [Related]
15. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT).
Lainas TG; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas GT; Alexopoulou E; Kolibianakis EM
Hum Reprod; 2010 Mar; 25(3):683-9. PubMed ID: 20008886
[TBL] [Abstract][Full Text] [Related]
16. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
17. Comparison between a GnRH agonist and a GnRH antagonist protocol for the same patient undergoing IVF.
Li Y; Li Y; Lai Q; Zhang H; Zhu G; Jin L; Yue J
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):618-20. PubMed ID: 18846352
[TBL] [Abstract][Full Text] [Related]
18. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
[TBL] [Abstract][Full Text] [Related]
19. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
Mohsen IA; El Din RE
Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
[TBL] [Abstract][Full Text] [Related]
20. Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol.
Xu B; Zhou M; Wang J; Zhang D; Guo F; Si C; Leung PCK; Zhang A
Hum Reprod; 2018 Jul; 33(7):1270-1280. PubMed ID: 29897458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
